2.46Open2.46Pre Close0 Volume12 Open Interest7.00Strike Price0.00Turnover247.12%IV4.22%PremiumAug 16, 2024Expiry Date2.26Intrinsic Value100Multiplier24DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type-0.6089Delta0.1259Gamma1.66Leverage Ratio-0.0230Theta-0.0033Rho-1.01Eff Leverage0.0048Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet